Back
Oncotelic Therapeutics, Inc. 10K Form
Sell
37
OTLC
Oncotelic Therapeutics, Inc.
Last Price:
$0.10
Seasonality Move:
-0.41%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OTLC News And Ratings
See the #1 stock for the next 7 days that we like better than OTLC
OTLC Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-307K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.02 |
| Price / Book: | 4.59 |
Profitability
| EPS (TTM): | -0.00410 |
|---|---|
| Net Income (TTM): | $-1.9M |
| Gross Margin: | $0 |
| Return on Equity: | -25.13% |
| Return on Assets: | -7.12% |
Oncotelic Therapeutics, Inc. Earnings Forecast
Key Oncotelic Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 33 years have been positive in 22 years.
Oncotelic Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | OTLC |
| Website: | oncotelic.com |
Debt
| Debt-to-Equity Ratio: | 1.61 |
|---|---|
| Current Ratio: | 0.08 |
| Quick Ratio: | 0.02 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
OTLC Technical Analysis vs Fundamental Analysis
Sell
37
Oncotelic Therapeutics, Inc. (OTLC)
is a Sell
Is Oncotelic Therapeutics, Inc. a Buy or a Sell?
-
Oncotelic Therapeutics, Inc. stock is rated a SellThe current Oncotelic Therapeutics, Inc. [OTLC] share price is $0.09. The Score for OTLC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.